Association Between Preexisting ILAs, Smoking History and ICI-Related Pneumonitis
Researchers investigated the association between preexisting interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis.
Researchers investigated the association between preexisting interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis.
Investigators believe their study is the first to demonstrate the adverse impact of LVI on overall survival in patients with surgically treated renal cell carcinoma.
Vascular endothelial growth factor inhibitors tied to hypertension among people aged 18 to 39 years being treated for renal cancer.
This review of computed tomography texture analysis shows its potential for monitoring treatment responses and tumor evolution over time, particularly in renal cell carcinoma.
Lung cancer patients treated with immune checkpoint inhibitors experience worse immune-related adverse event survival than other cancer patients.
Clinical pathway treatment regimens are associated with significant cost savings for patients with metastatic solid tumors, a study suggests.
An analysis of groundwater revealed 7 constituents — such as chlordane, dieldrin, and glyphosphate — that may increase the risk of kidney cancer.
Anti-PD-L1-based therapies may improve some outcomes over sunitinib in patients with metastatic renal cell carcinoma, a meta-analysis suggests.
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Blood type may impact immunotherapy outcomes in patients with metastatic RCC, a study suggests.